{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:16:31Z","timestamp":1788344191386,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.biopha.2018.03.126","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T18:15:36Z","timestamp":1524593736000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Nobiletin (NOB) suppresses autophagic degradation via over-expressing AKT pathway and enhances apoptosis in multidrug-resistant SKOV3\/TAX ovarian cancer cells"],"prefix":"10.1016","volume":"103","author":[{"given":"Ya-Ping","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.03.126_bib0005","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2018.03.126_bib0010","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygyno.2014.04.005","article-title":"Inhibition of Wnt\/\u03b2-catenin pathway by niclosamide: a therapeutic target for ovarian cancer","volume":"134","author":"Arend","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biopha.2018.03.126_bib0015","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1038\/srep08509","article-title":"MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer","volume":"5","author":"Yang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2018.03.126_bib0020","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2018.03.126_bib0025","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: an overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2018.03.126_bib0030","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nchem.2479","article-title":"Counting on natural products for drug design","volume":"8","author":"Rodrigues","year":"2016","journal-title":"Nat. Chem."},{"key":"10.1016\/j.biopha.2018.03.126_bib0035","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1016\/j.bmcl.2007.06.096","article-title":"Anti-inflammatory property of the urinary metabolites of nobiletin in mouse","volume":"17","author":"Li","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2018.03.126_bib0040","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2006.11.016","article-title":"Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells","volume":"251","author":"Morley","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2018.03.126_bib0045","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1111\/j.1349-7006.2010.01668.x","article-title":"Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis\u2010related endothelial cell functions and angiogenesis in vivo","volume":"101","author":"Kunimasa","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2018.03.126_bib0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbrc.2007.11.100","article-title":"A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells","volume":"366","author":"Miyata","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2018.03.126_bib0055","first-page":"1322","article-title":"The citrus flavonoid, nobiletin, inhibits peritoneal dissemination of human gastric carcinoma in SCID mice","volume":"92","author":"Minagawa","year":"2001","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2018.03.126_bib0060","doi-asserted-by":"crossref","first-page":"e838","DOI":"10.1038\/cddis.2013.350","article-title":"Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment","volume":"4","author":"Sui","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2018.03.126_bib0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3892\/mmr.2014.2671","article-title":"Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells","volume":"11","author":"Bao","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2018.03.126_bib0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","article-title":"Methods in mammalian autophagy research","volume":"140","author":"Mizushima","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.03.126_bib0075","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.03.126_bib0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1535-6108(03)00248-4","article-title":"Targeting the PI3K-Akt pathway in human cancer: rationale and promise","volume":"4","author":"Luo","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2018.03.126_bib0085","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1368-7646(02)00120-6","article-title":"Activation of the PI3K\/Akt pathway and chemotherapeutic resistance","volume":"5","author":"West","year":"2002","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.biopha.2018.03.126_bib0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt signalling pathway and cancer","volume":"30","author":"Vara","year":"2004","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.biopha.2018.03.126_bib0095","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/mTOR signaling in cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2018.03.126_bib0100","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/bjc.2013.789","article-title":"Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway","volume":"110","author":"Zhang","year":"2014","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.biopha.2018.03.126_bib0105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbadis.2014.04.029","article-title":"Role of autophagy in metabolic syndrome-associated heart disease","volume":"1852","author":"Ren","year":"2015","journal-title":"BBA-Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2018.03.126_bib0110","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cell.2016.09.030","article-title":"p62 in cancer: signaling adaptor beyond autophagy","volume":"167","author":"Moscat","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.03.126_bib0115","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/cdd.2012.10","article-title":"Impairment of lysosomal integrity by B10, a glycosylated derivative of betulinic acid, leads to lysosomal cell death and converts autophagy into a detrimental process","volume":"19","author":"Gonzalez","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2018.03.126_bib0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.18632\/oncoscience.147","article-title":"Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt\/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells","volume":"2","author":"Amantini","year":"2015","journal-title":"Oncoscience"},{"key":"10.1016\/j.biopha.2018.03.126_bib0125","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainres.2014.02.007","article-title":"Neuroprotective effect of nobiletin on cerebral ischemia\u2013reperfusion injury in transient middle cerebral artery-occluded rats","volume":"1559","author":"Yasuda","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2018.03.126_bib0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2014.03.013","article-title":"Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches","volume":"347","author":"Wu","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2018.03.126_bib0135","doi-asserted-by":"crossref","first-page":"R435","DOI":"10.1016\/j.cub.2014.04.012","article-title":"DNA replication and oncogene-induced replicative stress","volume":"24","author":"Hills","year":"2014","journal-title":"Curr. Biol."},{"key":"10.1016\/j.biopha.2018.03.126_bib0140","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cell.2013.12.011","article-title":"Premature activation of the SLX4 complex by Vpr promotes G2\/M arrest and escape from innate immune sensing","volume":"156","author":"Laguette","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.03.126_bib0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2014.09.017","article-title":"Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention","volume":"355","author":"Shukla","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2018.03.126_bib0150","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.1073\/pnas.1405663111","article-title":"Phosphatases reverse p53-mediated cell cycle checkpoints","volume":"111","author":"Donehower","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2018.03.126_bib0155","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrc3711","article-title":"Unravelling mechanisms of p53-mediated tumour suppression","volume":"14","author":"Bieging","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2018.03.126_bib0160","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cell.2008.03.025","article-title":"Acetylation is indispensable for p53 activation","volume":"133","author":"Tang","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.03.126_bib0165","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1600-0854.2008.00701.x","article-title":"The itinerary of autophagosomes: from peripheral formation to kiss\u2010and\u2010run fusion with lysosomes","volume":"9","author":"Jahreiss","year":"2008","journal-title":"Traffic"},{"key":"10.1016\/j.biopha.2018.03.126_bib0170","first-page":"220","article-title":"Autophagy is a therapeutic target in anticancer drug resistance","volume":"1806","author":"Chen","year":"2010","journal-title":"BBA-Rev. Cancer"},{"key":"10.1016\/j.biopha.2018.03.126_bib0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1756-9966-30-87","article-title":"Apoptosis in cancer: from pathogenesis to treatment","volume":"30","author":"Wong","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2018.03.126_bib0180","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrn2665","article-title":"Mitochondrial membrane permeabilization in neuronal injury","volume":"10","author":"Galluzzi","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biopha.2018.03.126_bib0185","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1242\/jcs.073643","article-title":"Regulation of the Apaf-1\u2013caspase-9 apoptosome","volume":"123","author":"Bratton","year":"2010","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.biopha.2018.03.126_bib0190","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/cdd.2008.131","article-title":"Control of autophagy by oncogenes and tumor suppressor genes","volume":"16","author":"Maiuri","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2018.03.126_bib0195","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.cell.2013.11.019","article-title":"Autophagy-mediated tumor promotion","volume":"155","author":"Guo","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.03.126_bib0200","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tox.2008.07.048","article-title":"Cell death and autophagy: cytokines, drugs, and nutritional factors","volume":"254","author":"Bursch","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.biopha.2018.03.126_bib0205","doi-asserted-by":"crossref","first-page":"856","DOI":"10.15252\/embj.201490784","article-title":"Autophagy in malignant transformation and cancer progression","volume":"34","author":"Galluzzi","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2018.03.126_bib0210","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.neuroscience.2009.08.014","article-title":"Rapamycin protects against rotenone-induced apoptosis through autophagy induction","volume":"164","author":"Pan","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2018.03.126_bib0215","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ijc.24757","article-title":"Cyclooxygenase\u20102 inhibition inhibits PI3K\/AKT kinase activity in epithelial ovarian cancer","volume":"126","author":"Uddin","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2018.03.126_bib0220","doi-asserted-by":"crossref","DOI":"10.1186\/1750-2187-5-10","article-title":"Inhibition of PI3K\/AKT and MAPK\/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer","volume":"5","author":"Roy","year":"2010","journal-title":"J. Mol. Signal."},{"key":"10.1016\/j.biopha.2018.03.126_bib0225","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.4049\/jimmunol.177.11.8266","article-title":"IL-22-mediated tumor growth reduction correlates with inhibition of ERK1\/2 and AKT phosphorylation and induction of cell cycle arrest in the G2-M phase","volume":"177","author":"Weber","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2018.03.126_bib0230","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.febslet.2010.01.017","article-title":"mTOR regulation of autophagy","volume":"584","author":"Jung","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2018.03.126_bib0235","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00277-008-0677-3","article-title":"Casticin induces leukemic cell death through apoptosis and mitotic catastrophe","volume":"88","author":"Shen","year":"2009","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.biopha.2018.03.126_bib0240","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/CAD.0b013e3283160fd6","article-title":"PI3K\/Akt is involved in bufalin-induced apoptosis in gastric cancer cells","volume":"20","author":"Li","year":"2009","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.biopha.2018.03.126_bib0245","doi-asserted-by":"crossref","first-page":"16183","DOI":"10.1074\/jbc.M109.002105","article-title":"Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt\/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression","volume":"284","author":"Wang","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.03.126_bib0250","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1021\/acs.molpharmaceut.5b00531","article-title":"A novel platinum\u2013maurocalcine conjugate induces apoptosis of human glioblastoma cells by acting through the ROS-ERK\/AKT-p53 pathway","volume":"12","author":"Aroui","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2018.03.126_bib0255","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/15384101.2017.1337968","article-title":"AKT modulates the autophagy-lysosome pathway via TFEB","volume":"16","author":"Palmieri","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.biopha.2018.03.126_bib0260","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nrc1738","article-title":"Lysosomes and autophagy in cell death control","volume":"5","author":"Kroemer","year":"2001","journal-title":"Nat. Rev. Cancer"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218312095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218312095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T01:46:49Z","timestamp":1720662409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218312095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":52,"alternative-id":["S0753332218312095"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.03.126","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nobiletin (NOB) suppresses autophagic degradation via over-expressing AKT pathway and enhances apoptosis in multidrug-resistant SKOV3\/TAX ovarian cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.03.126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}